Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $35.65 million versus the consensus estimate of $6.14 million.

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.